AbbVie Splits from Abbott; Humira Is a Top Priority
AbbVie Inc. launched Wednesday as an independent biopharma, splitting from Abbott in a plan initially disclosed in October 2011. AbbVie took several dozen marketed products and a portfolio of late-stage compounds in immunology, neuroscience and oncology.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST